Last month, drug company Genentech reported on the first clinical trials of the drug crenezumab, a drug targeting amyloid proteins that form sticky plaques in the brains of Alzheimer’s disease patients. The drug had been particularly effective in...
This has been known for a while, remember I listened to a podcast a while ago about this. Surprised there are still news stories being released on it as most of the scientific community has known about it for a while.
This has been known for a while, remember I listened to a podcast a while ago about this. Surprised there are still news stories being released on it as most of the scientific community has known about it for a while.